scorecard
  1. Home
  2. Science
  3. Health
  4. news
  5. 22 biotech companies that will likely get bought as M&A heats up this summer

22 biotech companies that will likely get bought as M&A heats up this summer

Lydia Ramsey Pflanzer   

22 biotech companies that will likely get bought as M&A heats up this summer
Science2 min read

Hello,

Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:

If you're new to this newsletter, sign up here. Comments, tips? Email me at lramsey@insider.com or tweet @lydiaramsey125. Let's get to it...


Top biotech analysts say M&A is set to heat up this summer. Here are the 22 drug companies that are likely to get bought.

See the full list>>


Experts explain why the mRNA tech that revolutionized COVID-19 vaccines could be the answer to incurable diseases, heart attacks, and even snake bites: 'The possibilities are endless'

Get the full story>>


Deadly fungi are becoming drug-resistant, and it's the next big public health threat, experts say

Here's what's at stake>>


More stories we're reading:


- Lydia

READ MORE ARTICLES ON


Advertisement

Advertisement